Peripheral Arterial Disease Clinical Trials in Boston, Massachusetts

5 studies are recruiting for peripheral arterial disease in Boston, Massachusetts right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Advanta VXT and Flixene PMCF Registry

   The purpose of the registry is to evaluate the long-term safety and performance of Advanta VXT and Flixene vascular grafts for repair or replacement of peripheral arteries. This registry is also intended to provide further data on the clinical usefulness of the Advanta VXT and Flixene vascular graf…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Massachusetts General Hospital, Boston, Massachusetts

   Locations

   2 in total

   Run by

   Atrium Medical Corporation

   See if you can join NCT07161583 on ClinicalTrials.gov

2. The GORE VBX FORWARD Clinical Study: A Comparison of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis to Bare Metal Stenting for Patients With Complex Iliac Occlusive Disease

   The objective of this prospective, multicenter, randomized, controlled clinical trial is to demonstrate the superiority of the VBX Device for primary patency when compared to bare metal stenting in complex iliac occlusive disease.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Beth Israel Deaconess Medical Center, Inc., Boston, Massachusetts

   Locations

   43 in total

   Run by

   W.L.Gore & Associates

   See if you can join NCT05811364 on ClinicalTrials.gov

3. SELUTION4BTK Trial

   This study aims to demonstrate superior efficacy and equivalent safety of the SELUTION SLR™ DEB 014 compared to plain (uncoated) balloon angioplasty in the treatment of peripheral arterial disease (PAD) in the BTK arteries in CLTI patients.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Beth Israel Medical Center, Boston, Massachusetts

   Locations

   48 in total

   Run by

   M.A. Med Alliance S.A.

   See if you can join NCT05055297 on ClinicalTrials.gov

4. PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia

   A prospective, single-arm, multi-center study designed to gather additional information on the LimFlow System.

   Stage

   Not phased

   Ages

   18 to 95

   Site

   Massachusetts General Hospital, Boston, Massachusetts

   Locations

   30 in total

   Run by

   LimFlow, Inc.

   See if you can join NCT05313165 on ClinicalTrials.gov

5. Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes

   XLPAD is an observational study designed to evaluate the effectiveness and use of stent and non-stent based therapies among PAD patients. The study will create a registry that will include entry of procedural and clinical follow-up information into an online data collection software, REDCAP.Data av…

   Stage

   Not phased

   Ages

   Any age

   Site

   VA Boston Healthcare System, Boston, Massachusetts

   Locations

   24 in total

   Run by

   Baylor Research Institute

   See if you can join NCT01904851 on ClinicalTrials.gov